Amarin Corporation plc (AMRN)

0,8699 +0,0098 (+1,14%) In data: 02:25PM EDT. Mercato aperto.

Amarin Corporation plc

Iconic Offices, The Greenway
Block C Ardilaun Court St Stephens Green
Dublin 112-114
Ireland
353 0 166 99020
https://www.amarincorp.com

Settore/i: Healthcare
Settore: Drug Manufacturers - General
Impiegati a tempo pieno: 275

Figure dirigenziali chiave

Nome	Titolo	Retribuzione	Esercitate	Anno di nascita
Mr. Patrick J. Holt	President, CEO & Director	678,88k	N/D	1973
Mr. Thomas Charles Reilly	Executive VP, CFO & Global Head of HR	1,01M	N/D	1973
Dr. Steven B. Ketchum Ph.D.	Executive VP, President of Research & Development and Chief Scientific Officer	1,16M	N/D	1965
Mr. Jonathan N. Provoost	Executive VP, Chief Legal & Compliance Officer and Secretary	160,08k	N/D	1970
Mr. Aaron D. Berg	Executive VP & President of U.S.	1,26M	N/D	1963
Mr. Jordan Zwick	Senior VP of Corporate Business Development & Investor Relations	N/D	N/D	1987
Mr. Laurent Abuaf	President of Europe & Senior VP	N/D	N/D	N/D
Dr. Nabil Abadir	Chief Medical Officer of Global Medical Affairs	N/D	N/D	N/D
Dr. David Keenan Ph.D.	Executive VP of Technical Operations & President of Europe	N/D	N/D	N/D

Gli importi risalgono al giorno 31 dicembre 2023 e i valori di compensazione riguardano l'anno fiscale che si chiude a tale data. La retribuzione include salari, bonus ecc. "Esercitate" è il valore delle opzioni esercitate durante l'anno fiscale. Valuta in USD.

Descrizione

Amarin Corporation plc, a pharmaceutical company, engages in the development and commercialization of therapeutics for the treatment of cardiovascular diseases in the United States, European countries, Canada, Lebanon, and the United Arab Emirates. The company offers VASCEPA, a prescription-only omega-3 fatty acid product, used as an adjunct to diet for reducing triglyceride levels in adult patients with severe hypertriglyceridemia. It sells its products principally to wholesalers and specialty pharmacy providers. The company has a collaboration with Mochida Pharmaceutical Co., Ltd. to develop and commercialize drug products and indications based on the active pharmaceutical ingredient in Vascepa. The company was formerly known as Ethical Holdings plc and changed its name to Amarin Corporation plc in 1999. Amarin Corporation plc was incorporated in 1989 and is headquartered in Dublin, Ireland.

Governance aziendale

L'ISS Governance QualityScore di Amarin Corporation plc al N/D è N/D. I criteri di valutazione fondamentali sono revisione: N/D; Consiglio di Amministrazione: N/D; diritti degli azionisti: N/D; retribuzione: N/D.

Punteggi di corporate governance forniti da Institutional Shareholder Services (ISS). I punteggi indicano il rango decile relativo all’indice o alla regione. Un punteggio di decile pari a 1 indica un governance risk più basso, mentre un punteggio di 10 indica un governance risk più alto.